ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 34,475,113
- Share change
- +599,788
- Total reported value
- $274,062,429
- Put/Call ratio
- 74%
- Price per share
- $7.95
- Number of holders
- 52
- Value change
- +$4,571,679
- Number of buys
- 29
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP H0036K147:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6%
|
7,681,046
|
$112,835,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
5.8%
|
7,432,429
|
$109,182,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.7%
|
3,414,630
|
$50,162,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.3%
|
2,957,056
|
$43,439,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.9%
|
2,462,636
|
$36,176,000 | — | 31 Mar 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,975,000
|
$29,013,000 | — | 31 Mar 2022 | |
| Vantage Consulting Group Inc |
13F
|
Company |
1.3%
|
1,680,149
|
$24,681,000 | — | 31 Mar 2022 | |
| Grosvenor Holdings, L.L.C. |
13F
|
Company |
1.2%
|
1,517,212
|
$22,288,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1%
|
1,295,018
|
$19,024,000 | — | 31 Mar 2022 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.39%
|
500,000
|
$7,345,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.33%
|
421,297
|
$6,189,000 | — | 31 Mar 2022 | |
| Matrix Capital Management Company, LP |
13F
|
Company |
0.31%
|
400,000
|
$5,876,000 | — | 31 Mar 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.26%
|
334,384
|
$4,912,000 | — | 31 Mar 2022 | |
| Employees Retirement System of Texas |
13F
|
Company |
0.24%
|
312,000
|
$4,583,000 | — | 31 Mar 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.24%
|
305,246
|
$4,484,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
304,229
|
$4,469,000 | — | 31 Mar 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.19%
|
248,354
|
$3,648,000 | — | 31 Mar 2022 | |
| Magnetar Financial LLC |
13F
|
Company |
0.13%
|
167,698
|
$2,463,000 | — | 31 Mar 2022 | |
| Indie Asset Partners, LLC |
13F
|
Company |
0.08%
|
96,572
|
$1,419,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
92,290
|
$1,356,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
85,864
|
$1,261,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
78,845
|
$1,158,000 | — | 31 Mar 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.06%
|
75,030
|
$1,102,000 | — | 31 Mar 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.05%
|
67,810
|
$997,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.05%
|
64,402
|
$951,862 | — | 31 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
28,949
|
$425,000 | — | 31 Mar 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.02%
|
24,971
|
$365,000 | — | 31 Mar 2022 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.02%
|
21,408
|
$314,000 | — | 31 Mar 2022 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.02%
|
19,469
|
$286,000 | — | 31 Mar 2022 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
19,193
|
$282,000 | — | 31 Mar 2022 | |
| CNA FINANCIAL CORP |
13F
|
Company |
0.01%
|
15,515
|
$228,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
7,609
|
$112,000 | — | 31 Mar 2022 | |
| Prospera Financial Services Inc |
13F
|
Company |
0%
|
5,921
|
$87,000 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
3,237
|
$47,000 | — | 31 Mar 2022 | |
| State of Wyoming |
13F
|
Company |
0%
|
2,882
|
$42,000 | — | 31 Mar 2022 | |
| Sterling Investment Advisors, Ltd. |
13F
|
Company |
0%
|
1,100
|
$16,000 | — | 31 Mar 2022 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0%
|
1,000
|
$15,000 | — | 31 Mar 2022 | |
| CWM, LLC |
13F
|
Company |
0%
|
950
|
$14,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
891
|
$13,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
737
|
$10,000 | — | 31 Mar 2022 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
350
|
$5,000 | — | 31 Mar 2022 | |
| Focused Wealth Management, Inc |
13F
|
Company |
0%
|
300
|
$4,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
200
|
$3,000 | — | 31 Mar 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
200
|
$2,000 | — | 31 Mar 2022 | |
| ASSETMARK, INC |
13F
|
Company |
0%
|
165
|
$2,000 | — | 31 Mar 2022 | |
| SALEM INVESTMENT COUNSELORS INC |
13F
|
Company |
0%
|
35
|
$1,000 | — | 31 Mar 2022 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q2 2022
As of 30 Jun 2022,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,475,113 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., PRICE T ROWE ASSOCIATES INC /MD/, EVENTIDE ASSET MANAGEMENT, LLC, GCM Grosvenor Holdings, LLC, PICTET ASSET MANAGEMENT SA, Vantage Consulting Group Inc, and Walleye Capital LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
44
Q2 2022 holders
52
Holder diff
8
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.